mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.09 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.1 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |
mRNA |
BIRB 0796 |
FIMM |
pan-cancer |
AAC |
0.31 |
0.1 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |